Ipilimumab

Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

hm, interesting. I did not know CTLA-4 inhibitors were this close to becoming used in clinical settings. I could definitely see this drug causing problems with overreactive t cells, especially in patients who may be susceptible to auto immune disease.